A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus.
about
Management of Adults With Diabetes and Cognitive ProblemsSwitching basal insulins in type 2 diabetes: practical recommendations for health care providers.Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements.Efficacy and Safety of Insulin Degludec versus Insulin Glargine: A Systematic Review and Meta-Analysis of Fifteen Clinical Trials.
P2860
A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Multinational, Randomized, O ...... with Type 2 Diabetes Mellitus.
@en
type
label
A Multinational, Randomized, O ...... with Type 2 Diabetes Mellitus.
@en
prefLabel
A Multinational, Randomized, O ...... with Type 2 Diabetes Mellitus.
@en
P2093
P2860
P1433
P1476
A Multinational, Randomized, O ...... with Type 2 Diabetes Mellitus.
@en
P2093
Changyu Pan
Charlotte Thim Hansen
Hongfei Xu
Jorge L Gross
Robert Wagner
Wenying Yang
Xiaofeng Lv
P2860
P304
P356
10.1007/S40268-016-0134-Z
P577
2016-04-20T00:00:00Z